Ratnakar Securities Pvt. Ltd.

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal

BSE2348.85119.85 (+5.38 %)

PREV CLOSE ( ) 2229.00

OPEN PRICE ( ) 2238.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 26300

TODAY'S LOW / HIGH ( )2213.00 2406.10

52 WK LOW / HIGH ( )1888.85 2766.85

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 14-02 1995

Management Info

Arvind Lal - Chairman Om Prakash Manchanda - Managing Director

Registered Office

Address Block E,Sector 18,Rohini,
New Delhi,
Delhi-110085

Phone 011-49885050

Email cs@lalpathlabs.com

Website www.lalpathlabs.com

Registrars Details

Link Intime India Pvt Ltd.

Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi

Listing : BSE, NSE

NEWS

03May Dr. Lal PathLabs informs about board m
Dr. Lal PathLabs has informed that a meeting of the Board of Directors i..

26Mar Dr. Lal PathLabs informs about closure
Dr. Lal PathLabs has informed that as per the provisions of the SEBI (Pr..

18Mar Dr. Lal PathLabs informs about outcome
Dr. Lal PathLabs has informed that, based on recommendations of Nominati..

18Mar Board Meeting Outcome for Appointment
Based on recommendations of Nomination & Remuneration Committee, the Boa..

01Feb Dr. Lal PathLabs informs about earning
Dr. Lal PathLabs has informed that it attached a copy of Company's Q3 &a..

Financials

in Millions

	QTR Mar 24	ANNUAL 24
Net Profit	895	3844
Gross Profit	1205	5160
Operating Profit	1462	6193
Net Sales	4790	19668

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 3449.00 (4.67%)	M.Cap ( in Cr)1621.03
Kovai Medical Center (BSE) 3915.75 (3.19%)	M.Cap ( in Cr)4284.72
Vijaya Diagnostic (BSE) 801.50 (9.55%)	M.Cap ( in Cr)8216.66
Apollo Hospital Ent. (BSE) 5834.10 (0.45%)	M.Cap ( in Cr)83885.41
Metropolis Health. (BSE) 1746.05 (1.51%)	M.Cap ( in Cr)8944.81

Shareholding Pattern

	NON-INSTITUTION	9.56%
	MUTUAL FUNDS/UTI	6.79%
	PROMOTERS	54.6%
	FI/BANKS/INSURANCE	2.3%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
HSBC Arbitrage Fund...	1.57
360 ONE Flexicap Fu...	1.52
UTI Flexi Cap Fund-...	1.49
UTI Mid Cap Fund-Re...	1.21
DSP Nifty Midcap 15...	1.20
Mirae Asset Healthc...	1.20

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

DR. LAL PATHLABS LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES